- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
DC-based Immunotherapy for T1D
CIT researchers demonstrate that DC therapy leads to long-lasting immunomodulatory effects in an antigen-dependent and antigen-independent manner.
A New Nanoscale Technology
Proteomic profiling of single human pancreatic islet sections using a new nanoscale technology called nanoPOTS
Processed EEG Monitoring Devices for Assessment of Depth of Anesthesia
CIT members discuss the advantages and limitations of this technology in the clinical setting as a tool in our repertoire used for optimizing individualized patient care.
Metformin attenuates the Type I Interferon response in human peripheral blood leukocytes
CIT researchers provide evidence that the therapeutic potential of metformin in lupus may be multifaceted, including the modulation of type I IFN stimulated genes, as well as STAT3 signaling.
CIT Members Make News
UF Diabetes Institute researchers discover way to expand potent regulatory cells
The Journal of Pain
CIT member, Dr. Shannon Wallet, finds peripheral mechanisms involved in the response to pain may change with age.
Recent News
CIT Members Make News
Apr 21st, 2017
UF Diabetes Institute researchers discover way to expand potent regulatory cells
The Journal of Pain
Apr 18th, 2017
CIT member, Dr. Shannon Wallet, finds peripheral mechanisms involved in the response to pain may change with age.